AMA CPT® Assistant - 2006 Issue 10 (October)
Coding Clarification: Pathology and Laboratory--Chemistry (October 2006)
October 2006 page 15 Pathology and Laboratory-Chemistry, 83037 (Q&A) The following is provided in response to a previously published article titled Changes to Pathology and Laboratory-Part I from the February 2006 CPT Assistant (page 7) and CPT Changes 2006: An Insider's View (page 188). The following excerpt is followed by a question and answer that clarifies the previously published discussion of code 83037, Hemoglobin; glycosylated (A1C) by device cleared by FDA for home use. CPT code 83036, Hemoglobin; glycosylated (A1C), was revised to replace the word "glycated" with "glycosylated (A1C)" to better reflect current nomenclature. CPT code 83037...
Subscribe or sign in to view the full article.
Article Overview
This article is a brief coding clarification from CPT Assistant focused on pathology and laboratory chemistry. It explains the context behind a revised glycosylated hemoglobin topic, discusses the broader clinical and administrative significance of A1C testing in diabetes care, and answers a question about how the related CPT guidance should be interpreted. It is most relevant to coders, billers, compliance staff, and laboratory professionals working with CPT-based reporting.
Why This Topic Matters
It helps readers understand the scope of a specific CPT laboratory reporting topic in relation to diabetes testing and patient-encounter documentation.
What You Will Learn
- The general coding context for a laboratory chemistry clarification.
- How A1C testing is discussed in relation to diabetes care.
- The type of question-and-answer guidance provided by CPT Assistant.
- The clinical and administrative setting addressed by the article.
Who Should Read This
- Medical coders
- Coding auditors
- Compliance staff
- Laboratory professionals
- Billing staff
- Physicians and clinical practices
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com
